Epstein–Barr virus (EBV) is perhaps best known for itsability to immortalize human B lymphocytes in culture.1 Thisproperty makes it a candidate for causing human disease, particularlycancer and autoimmune disease.2,3 Recent work, however, hasshown that EBV has evolved strategies that reduce its potentialto become pathogenic.4,5,6 These new findings have encourageda reassessment of how and when EBV may cause human disease.In this article, we review current knowledge of the ways inwhich EBV establishes and maintains a persistent infection atthe same time that it minimizes its pathogenicity; we also discusshow these characteristics influence . . . [Full Text of this Article]
EBV Infection
In Vitro and in Vivo Infection
The Persistence of EBV
Resolution of the Infection
Minimizing the Pathogenic Effect of EBV
Other Interpretations
EBV and Epithelium
EBV and Disease
Lymphoma in Immunosuppressed Patients
Hodgkin's Disease
Burkitt's Lymphoma
Conclusions
Source Information
From the Department of Pathology, Tufts University School of Medicine (D.A.T.-L.), and the Department of Rheumatology, Tufts–New England Medical Center (A.G.) — both in Boston.
Address reprint requests to Dr. Thorley-Lawson at the Department of Pathology, Jaharis Bldg., Tufts University School of Medicine, 150 Harrison Ave., Boston, MA 02111, or at david.thorley-lawson@tufts.edu.
Baldanti, F., Gatti, M., Furione, M., Paolucci, S., Tinelli, C., Comoli, P., Merli, P., Locatelli, F.
(2008). Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation. J. Clin. Microbiol.
46: 3672-3677
[Abstract][Full Text]
Cocco, M., Bellan, C., Tussiwand, R., Corti, D., Traggiai, E., Lazzi, S., Mannucci, S., Bronz, L., Palummo, N., Ginanneschi, C., Tosi, P., Lanzavecchia, A., Manz, M. G., Leoncini, L.
(2008). CD34+ Cord Blood Cell-Transplanted Rag2-/- {gamma}c-/- Mice as a Model for Epstein-Barr Virus Infection. Am. J. Pathol.
173: 1369-1378
[Abstract][Full Text]
Anderson, L. J., Longnecker, R.
(2008). EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J. Gen. Virol.
89: 1563-1568
[Abstract][Full Text]
Wiedmer, A., Wang, P., Zhou, J., Rennekamp, A. J., Tiranti, V., Zeviani, M., Lieberman, P. M.
(2008). Epstein-Barr Virus Immediate-Early Protein Zta Co-Opts Mitochondrial Single-Stranded DNA Binding Protein To Promote Viral and Inhibit Mitochondrial DNA Replication. J. Virol.
82: 4647-4655
[Abstract][Full Text]
Young, L. S
(2008). Epstein-Barr Virus Infection: From Persistence to Pathogenesis. aacredbook
2008: 363-366
[Abstract][Full Text]
Chau, C. M., Deng, Z., Kang, H., Lieberman, P. M.
(2008). Cell Cycle Association of the Retinoblastoma Protein Rb and the Histone Demethylase LSD1 with the Epstein-Barr Virus Latency Promoter Cp. J. Virol.
82: 3428-3437
[Abstract][Full Text]
Guasparri, I., Bubman, D., Cesarman, E.
(2008). EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood
111: 3813-3820
[Abstract][Full Text]
Liu, A., Claesson, H.-E., Mahshid, Y., Klein, G., Klein, E.
(2008). Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures. Blood
111: 2693-2703
[Abstract][Full Text]
Bhaduri-McIntosh, S., Rotenberg, M. J., Gardner, B., Robert, M., Miller, G.
(2008). Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines. Blood
111: 1334-1343
[Abstract][Full Text]
Hadinoto, V., Shapiro, M., Greenough, T. C., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A.
(2008). On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood
111: 1420-1427
[Abstract][Full Text]
Fafi-Kremer, S., Morand, P., Barranger, C., Bargues, G., Magro, S., Bes, J., Bourgeois, P., Joannes, M., Seigneurin, J.-M.
(2008). Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms. J. Mol. Diagn.
10: 78-84
[Abstract][Full Text]
Wilson, S. J., Tsao, E. H., Webb, B. L. J., Ye, H., Dalton-Griffin, L., Tsantoulas, C., Gale, C. V., Du, M.-Q., Whitehouse, A., Kellam, P.
(2007). X Box Binding Protein XBP-1s Transactivates the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) ORF50 Promoter, Linking Plasma Cell Differentiation to KSHV Reactivation from Latency. J. Virol.
81: 13578-13586
[Abstract][Full Text]
Delecluse, H-J, Feederle, R, O'Sullivan, B, Taniere, P
(2007). Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol.
60: 1358-1364
[Abstract][Full Text]
Mancao, C., Hammerschmidt, W.
(2007). Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood
110: 3715-3721
[Abstract][Full Text]
Bollard, C. M., Gottschalk, S., Leen, A. M., Weiss, H., Straathof, K. C., Carrum, G., Khalil, M., Wu, M.-f., Huls, M. H., Chang, C.-C., Gresik, M. V., Gee, A. P., Brenner, M. K., Rooney, C. M., Heslop, H. E.
(2007). Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood
110: 2838-2845
[Abstract][Full Text]
Martin, H. J., Lee, J. M., Walls, D., Hayward, S. D.
(2007). Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus. J. Virol.
81: 9748-9758
[Abstract][Full Text]
Fukuda, M., Longnecker, R.
(2007). Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway. J. Virol.
81: 9299-9306
[Abstract][Full Text]
Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R., Kagami, Y., Morishima, Y., Takeuchi, K., Izumo, T., Mori, S., Ohshima, K., Suzumiya, J., Nakamura, N., Abe, M., Ichimura, K., Sato, Y., Yoshino, T., Naoe, T., Shimoyama, Y., Kamiya, Y., Kinoshita, T., Nakamura, S.
(2007). Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients. Clin. Cancer Res.
13: 5124-5132
[Abstract][Full Text]
Hjalgrim, H., Ekstrom-Smedby, K., Rostgaard, K., Amini, R.-M., Molin, D., Hamilton-Dutoit, S., Schollkopf, C., Chang, E. T., Ralfkiaer, E., Adami, H.-O., Glimelius, B., Melbye, M.
(2007). Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study. Cancer Epidemiol. Biomarkers Prev.
16: 1561-1566
[Abstract][Full Text]
Day, L., Chau, C. M., Nebozhyn, M., Rennekamp, A. J., Showe, M., Lieberman, P. M.
(2007). Chromatin Profiling of Epstein-Barr Virus Latency Control Region. J. Virol.
81: 6389-6401
[Abstract][Full Text]
Castiglione, F., Duca, K., Jarrah, A., Laubenbacher, R., Hochberg, D., Thorley-Lawson, D.
(2007). Simulating Epstein-Barr virus infection with C-ImmSim. Bioinformatics
23: 1371-1377
[Abstract][Full Text]
MacArthur, G. J., Wilson, A. D., Birchall, M. A., Morgan, A. J.
(2007). Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells. J. Virol.
81: 4766-4775
[Abstract][Full Text]
Streblow, D. N., van Cleef, K. W. R., Kreklywich, C. N., Meyer, C., Smith, P., Defilippis, V., Grey, F., Fruh, K., Searles, R., Bruggeman, C., Vink, C., Nelson, J. A., Orloff, S. L.
(2007). Rat Cytomegalovirus Gene Expression in Cardiac Allograft Recipients Is Tissue Specific and Does Not Parallel the Profiles Detected In Vitro. J. Virol.
81: 3816-3826
[Abstract][Full Text]
Hjalgrim, H., Ekstrom Smedby, K., Rostgaard, K., Molin, D., Hamilton-Dutoit, S., Chang, E. T., Ralfkiaer, E., Sundstrom, C., Adami, H.-O., Glimelius, B., Melbye, M.
(2007). Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma. Cancer Res.
67: 2382-2388
[Abstract][Full Text]
Engels, E. A.
(2007). Infectious Agents as Causes of Non-Hodgkin Lymphoma. Cancer Epidemiol. Biomarkers Prev.
16: 401-404
[Abstract][Full Text]
Rovedo, M., Longnecker, R.
(2007). Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity. J. Virol.
81: 84-94
[Abstract][Full Text]
Leao, M., Anderton, E., Wade, M., Meekings, K., Allday, M. J.
(2007). Epstein-Barr Virus-Induced Resistance to Drugs That Activate the Mitotic Spindle Assembly Checkpoint in Burkitt's Lymphoma Cells. J. Virol.
81: 248-260
[Abstract][Full Text]
Venugopal, P., Gregory, S. A.
(2007). Lymphoproliferative disorders. ASH-SAP
2007: 265-297
[Full Text]
Konforte, D., Paige, C. J.
(2006). Identification of Cellular Intermediates and Molecular Pathways Induced by IL-21 in Human B Cells. J. Immunol.
177: 8381-8392
[Abstract][Full Text]
Chau, C. M., Zhang, X.-Y., McMahon, S. B., Lieberman, P. M.
(2006). Regulation of Epstein-Barr Virus Latency Type by the Chromatin Boundary Factor CTCF.. J. Virol.
80: 5723-5732
[Abstract][Full Text]
Lunemann, J. D., Edwards, N., Muraro, P. A., Hayashi, S., Cohen, J. I., Munz, C., Martin, R.
(2006). Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain
129: 1493-1506
[Abstract][Full Text]
LaCasce, A. S.
(2006). Post-transplant lymphoproliferative disorders.. The Oncologist
11: 674-680
[Abstract][Full Text]
Hayward, S. D., Liu, J., Fujimuro, M.
(2006). Notch and Wnt Signaling: Mimicry and Manipulation by Gamma Herpesviruses. Sci Signal
2006: re4-re4
[Abstract][Full Text]
Adhikary, D., Behrends, U., Moosmann, A., Witter, K., Bornkamm, G. W., Mautner, J.
(2006). Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. JEM
203: 995-1006
[Abstract][Full Text]
Suarez, F., Lortholary, O., Hermine, O., Lecuit, M.
(2006). Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood
107: 3034-3044
[Abstract][Full Text]
Williams, H., Crawford, D. H.
(2006). Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood
107: 862-869
[Abstract][Full Text]
Pegtel, D. M., Subramanian, A., Sheen, T.-S., Tsai, C.-H., Golub, T. R., Thorley-Lawson, D. A.
(2005). Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis. J. Virol.
79: 15430-15442
[Abstract][Full Text]
Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A.
(2005). Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc. Natl. Acad. Sci. USA
102: 18093-18098
[Abstract][Full Text]
Tarakanova, V. L., Suarez, F., Tibbetts, S. A., Jacoby, M. A., Weck, K. E., Hess, J. L., Speck, S. H., Virgin, H. W. IV
(2005). Murine Gammaherpesvirus 68 Infection Is Associated with Lymphoproliferative Disease and Lymphoma in BALB {beta}2 Microglobulin-Deficient Mice. J. Virol.
79: 14668-14679
[Abstract][Full Text]
Thijsen, S. F. T., Luderer, R., van Gorp, J. M. H., Oudejans, S. J. G., Bossink, A. W. J.
(2005). A possible role for Epstein-Barr virus in the pathogenesis of pleural effusion. Eur Respir J
26: 662-666
[Abstract][Full Text]
Wu, L., Borza, C. M., Hutt-Fletcher, L. M.
(2005). Mutations of Epstein-Barr Virus gH That Are Differentially Able To Support Fusion with B Cells or Epithelial Cells. J. Virol.
79: 10923-10930
[Abstract][Full Text]
Moser, J. M., Upton, J. W., Allen, R. D. III, Wilson, C. B., Speck, S. H.
(2005). Role of B-Cell Proliferation in the Establishment of Gammaherpesvirus Latency. J. Virol.
79: 9480-9491
[Abstract][Full Text]
Kuppers, D. A., Lan, K., Knight, J. S., Robertson, E. S.
(2005). Regulation of Matrix Metalloproteinase 9 Expression by Epstein-Barr Virus Nuclear Antigen 3C and the Suppressor of Metastasis Nm23-H1. J. Virol.
79: 9714-9724
[Abstract][Full Text]
Bellan, C., Lazzi, S., Hummel, M., Palummo, N., de Santi, M., Amato, T., Nyagol, J., Sabattini, E., Lazure, T., Pileri, S. A., Raphael, M., Stein, H., Tosi, P., Leoncini, L.
(2005). Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood
106: 1031-1036
[Abstract][Full Text]
Fukuda, M., Longnecker, R.
(2005). Epstein-Barr Virus (EBV) Latent Membrane Protein 2A Regulates B-Cell Receptor-Induced Apoptosis and EBV Reactivation through Tyrosine Phosphorylation. J. Virol.
79: 8655-8660
[Abstract][Full Text]
Gross, A. J., Hochberg, D., Rand, W. M., Thorley-Lawson, D. A.
(2005). EBV and Systemic Lupus Erythematosus: A New Perspective. J. Immunol.
174: 6599-6607
[Abstract][Full Text]
Touitou, R., O'Nions, J., Heaney, J., Allday, M. J.
(2005). Epstein-Barr virus EBNA3 proteins bind to the C8/{alpha}7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J. Gen. Virol.
86: 1269-1277
[Abstract][Full Text]
Grulich, A. E., Vajdic, C. M., Kaldor, J. M., Hughes, A. M., Kricker, A., Fritschi, L., Turner, J. J., Milliken, S., Benke, G., Armstrong, B. K.
(2005). Birth Order, Atopy, and Risk of Non-Hodgkin Lymphoma. JNCI J Natl Cancer Inst
97: 587-594
[Abstract][Full Text]
Moser, J. M., Upton, J. W., Gray, K. S., Speck, S. H.
(2005). Ex Vivo Stimulation of B Cells Latently Infected with Gammaherpesvirus 68 Triggers Reactivation from Latency. J. Virol.
79: 5227-5231
[Abstract][Full Text]
Willer, D. O., Speck, S. H.
(2005). Establishment and Maintenance of Long-Term Murine Gammaherpesvirus 68 Latency in B Cells in the Absence of CD40. J. Virol.
79: 2891-2899
[Abstract][Full Text]
Park, S. S., Kim, J. S., Tessarollo, L., Owens, J. D., Peng, L., Han, S. S., Tae Chung, S., Torrey, T. A., Cheung, W. C., Polakiewicz, R. D., McNeil, N., Ried, T., Mushinski, J. F., Morse, H. C. III, Janz, S.
(2005). Insertion of c-Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice. Cancer Res.
65: 1306-1315
[Abstract][Full Text]
Voo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., Wang, R.-F.
(2005). Functional Characterization of EBV-Encoded Nuclear Antigen 1-Specific CD4+ Helper and Regulatory T Cells Elicited by In vitro Peptide Stimulation. Cancer Res.
65: 1577-1586
[Abstract][Full Text]
Liu, A., Arbiser, J. L., Holmgren, A., Klein, G., Klein, E.
(2005). PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. Blood
105: 1606-1613
[Abstract][Full Text]
Laichalk, L. L., Thorley-Lawson, D. A.
(2005). Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo. J. Virol.
79: 1296-1307
[Abstract][Full Text]
Heslop, H. E.
(2005). Biology and Treatment of Epstein-Barr Virus-Associated Non-Hodgkin Lymphomas. ASH Education Book
2005: 260-266
[Abstract][Full Text]
Chau, C. M., Lieberman, P. M.
(2004). Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus. J. Virol.
78: 12308-12319
[Abstract][Full Text]
Pegtel, D. M., Middeldorp, J., Thorley-Lawson, D. A.
(2004). Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic Carriers. J. Virol.
78: 12613-12624
[Abstract][Full Text]
Cornelissen, J. J.
(2004). Molecular monitoring of EBV-positive lymphoma. Blood
104: 9-9
[Full Text]
Rossi, G., Bonetti, F., Thorley-Lawson, D. A.
(2004). EBV and Burkitt's Lymphoma. NEJM
350: 2621-2621
[Full Text]
Previous
